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Abstract: The tumor microenvironment may recruit monocytes, with a protumoral macrophage phenotype (M2) that plays an
important role in solid tumor progression and metastasis. Therefore, it is necessary to understand the characteristics of these cells for
cancer prevention and treatment. Bladder cancer tissue samples and paracarcinoma tissues samples were collected, and the expression
of CD163+ cells in tumor tissues was observed. Then, we observed the expression of infiltrating CD45+CD14+CD163+ cell subset and
analyzed the molecular expressions related to immunity and angiogenesis. C57/BL6 mice were inoculated subcutaneously, and dynamic
changes of CD11b+F4/80+CD206+ mononuclear macrophages expression for tumor-bearing mice were detected. The results showed
that the proportion of CD45+CD14+CD163+ mono-macrophage subset infiltrated by tumor tissue was significantly higher than that in
paracarcinoma tissues. In bladder cancer tissue, the expression rate of CD40 in CD45+CD14+CD163- mono-macrophage subset was
significantly lower than that in CD45+CD14+CD163+ mono-macrophage subset. Similar results were found in the paracarcinoma tissues.
We found that, as the proportion of CD11b+F4/80+CD206+ mono-macrophages increased gradually, the difference was statistically
significant. CD163+/CD206+ mono-macrophages in bladder cancer microenvironment are abnormally elevated, and these cells are
closely related to tumor progression. CD40 may be an important molecule that exerts biological function in this subset.
Key words: Bladder cancer, tumor microenvironment, mono-macrophage, CD40

1. Introduction
Bladder carcinoma is one of the most common urologic
malignancies worldwide and is a heterogeneous disease
(Siegel et al., 2018). In 2019, the American Cancer Society
estimated 80,470 new cases of bladder cancer and 17,670
deaths due to bladder cancer in the United States (Siegel
et al., 2019). In China, the incidence and mortality rates
of bladder cancer have gradually increased in recent years
(Chen et al., 2016; Zheng et al., 2018). Noninvasive, welldifferentiated tumors have a relatively indolent natural
history, whereas poorly differentiated tumors are prone
to invade and metastasize. The clinical importance of
metastasis, the mechanisms facilitating the progression
from benign to invasive and finally to metastatic cancer
remain poorly understood. Bladder cancer and other solid
tumors contain a number of infiltrating immune cells,
predominantly macrophages (Maniecki et al., 2012).
High density of M2 mono-macrophages was
significantly associated with late clinical staging in patients
with bladder cancer. In response to different environment
stimuli, macrophages can appear as a range of different
phenotypes (Zhang et al., 2012). The expression of CD163

mono-macrophages in bladder cancer tissue are believed
to play a key role in the growth, progression and metastasis
of tumors by producing growth factors, proteases and
cytokines, which promote neoangiogenesis, connective
tissue breakdown, scavenging of cellular debris and tumorcell proliferation (Maniecki et al., 2012). Compared with
CD68, CD163 is regarded as a highly specific monocyte/
macrophage marker for M2 macrophages (Maniecki
et al., 2012; Medrek et al., 2012). Mono-macrophages
infiltrating the microenvironment of tumors are usually
labeled with the leukocyte marker CD45, and the monomacrophage marker molecules CD14 and CD45+CD4+
flow gate strategy defines tissue infiltrating monocyte
macrophages (Vidal et al., 2012; Sylvester et al., 2018).
Here, CD45 was used to detect leukocytes, rather than
examine CD14, as CD45 can eliminate the interference of
other cells to the greatest extent, and the measurement is
more accurate (Coppin et al., 2017; Sylvester et al., 2018).
CD40 is an important costimulatory molecule that plays
an important role in T cell immune regulation. CD40
is mainly expressed on the surface of B lymphocytes,
mono-macrophages and dendritic cells. CD40L is mainly
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expressed on the surface of T cells and is a CD40 ligand.
On the one hand, CD40-CD40L, which plays an important
role in antiviral and anticancer responses, regulates the
T cell immune response. On the other hand, CD40 can
activate mono-macrophages and release inflammatory
mediators. CD40-CD40L also plays a key role in mediating
angiogenesis and tumor growth (Gutierrez et al., 2019).
CD206, a carbohydrate-binding receptor expressed
by select populations of macrophages, dendritic cells
and nonvascular endothelium, is a heavily glycosylated
molecule, and its N-glycosylation sites are highly
conserved between humans and mice. CD206 function
can be altered through proteolytic cleavage and changes
in glycosylation and conformation (Martinez-Pomares,
2012), which is also a typical marker of M2 macrophages.
In recent years, extensive research has suggested that
angiogenesis in bladder cancer contributed to tumor
growth and progression (Fus and Górnicka, 2016). By
collecting bladder cancer tissue samples, the expressions
of CD163+ cells and related membrane molecules in the
mono-macrophage subset were analyzed, and the relevant
mechanism and clinical significance of how this mono-

macrophage subset exerted biological function were
discussed.
2. Materials and methods
2.1. Materials
The anti-human antibodies were purchased from US
Biolegend and US R&D System and US Biolegend. Cell
Lines: Mouse-derived long-term cell strain MB49 cells
were derived from American Merck and placed in a 5%
CO2 humidified incubator for subculturing (MB49 cells
were derived from C57BL/Icrf-a’ mouse bladder epithelial
cells that were transformed by a single 24-h treatment with
DMBA).
2.2. Flow cytometry program for bladder cancer tissue
of patients
(1) Eight patients with primary bladder cancer were
included in this study. Biopsies were obtained from
transurethral tumor resections, and aliquots were frozen
immediately. Samples for histological examination were
removed before freezing. Two patients received radical
cystectomies, and 6 patients were treated by transurethral
tumor resections and received intravesical pirarubicin

Table. Clinical data and patient characteristics.
No. of patients
%
(bladder cancer)
8

No. of patients*
%
(paracarcinoma)
3

Median

66.13

72.67

Range

50-81

65-81

Variables
Patients
Age (years)

Gender
Male

6

75.0 2

66.7

Female

2

25.0 1

33.3

Ta

5

62.5 2

66.7

T1

2

25.0 1

33.3

T2-T4

1

12.5 0

0

I/II

5

62.5 2

66.7

III/IV

3

37.5 1

33.3

< 3 cm

6

75.0 3

100

≥ 3 cm

2

25.0 0

Clinical stage of tumor

Tumor grade

Tumor size

Abbreviations: Ta, superficial tumors; T1, connective tissue-invasive
tumors; T2-T4, muscle-invasive tumors
﹡ Stage and grade in the paracarcinoma group were determined by bladder
cancer.
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therapy. The patient clinical data are summarized in Table.
Tissue cell processing: the cancerous tissue and distal noncancerous tissue of the same bladder cancer patient was
collected (confirmed by pathology as normal tissue, at
least 2cm away from the edge of the cancer). The study
was reviewed and approved by the Ethics Committee of
the First Affiliated Hospital of Soochow University, and
all patients signed the informed consent (2016 Ethics
(application) Lot No. 000-1); the tissues were washed with
precooled PBS to remove free erythrocytes. After being
cut into pieces, they were placed in 1640 culture medium
(volume 1 mL) containing 0.1% collagenase IV (Sigma,
USA) and incubated in a 37 °C incubator for shaking
reaction for 1 h. Subsequently, the resuspended pre-chilled
phosphate buffered solution (PBS) (5 mL) was ground, and
then cell resuspension solution was obtained; after that,
30μm filter (Miltenyi Biotec, Germany) was used to remove
islet-like cell cluster to obtain a single cell suspension. (2)
Expression of CD163+ mono-macrophage in the tissue:
make gates by anti-CD45-PC7+anti-CD14-FITC antibody,
mono-macrophages infiltrated by the tissue and defined
as CD45+CD14+ were measured by flow cytometry.
Experimental group: anti-CD45-PC7+anti-CD14-FITC
was as basic anti-body; anti-CD163-APC was added to
the experimental group; anti-IgG-APC was added into the
control group; after being mixed, make reactions on ice
for 30 min, being washed with PBS for once; after being
resuspended, CD45+CD14+ was the characteristic of monomacrophage expression to make gates, and the expression
of infiltrating CD45+CD14+CD163+ mono-macrophage
subset in bladder cancer and adjacent tissues was detected.
(3) Comparative analysis of CD163+ and CD163- monomacrophage phenotype: on the basis of the research
approach above, CD163 antibody was used to make gates,
the expression of membrane molecule Tie-2, PD-L1,
CD31 and CD40 as well as VEGFR2 and other molecules
in CD45+CD14+CD163- and CD45+CD14+CD163- monomacrophage subset were analyzed by flow cytometry, and
meanwhile immunoglobulin G (IgG) was set as the same
type of control. Specific streaming operation scheme was
the same as the former.
2.3. Fluorescence microscopy
(1) Slice preparation: fresh bladder cancer tissues were
dehydrated respectively with 10%, 20% and 30% (v/v)
in gradient sucrose for 24 h after being fixed with 4%
paraformaldehyde overnight; dehydrated tissue in optimal
cutting temperature (OCT) compound was placed in –80
°C low temperature refrigerator for preservation. The
frozen tissue was cut into continuous slices with 7-μm
thick by a Leica Freezing Automatic Microtome and placed
in a –20 °C low-temperature refrigerator for storage.
(2) Antibody staining: lyophilized sections were soaked
in ice-cold acetone for 10 min, then let it dry at room
temperature, and drew the outline of the tissue with a PAP
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pen; Sections and 5% bovine serum albumin (BSA) were
sealed for 1 h at room temperature; the section area was
completely covered with fluorescent antibody (CD14-FITC
and CD163-APC) after being diluted by 10-fold 0.1% BSA
(about 100μL), and the reaction was shaken for 1 h at 4 °C.
After being soaked thoroughly in PBS for 3 times, it (the
section) was sealed with 4’, 6-diamidino-2-phenylindole
(DAPI) glycerol solution. (3) Microscopy: the expression
of CD163 was observed by Leica fluorescence microscope
(× 400), and records and pictures were made.
2.4. Construct bladder cancer tumor-bearing mouse
model
A total number of 18 adult female C57BL/6 mice with
weights in the range of 16–20g (Shanghai Slack Laboratory
Animal Co., Ltd.) were raised in the specific pathogen free
(SPF) experimental animal center and were provided by
the Laboratory Animal Center of Soochow University
with the license number SYXK(Su) 2012-0045 (2016
Ethics (application) Lot No.000-2). The murine bladder
cancer cell line MB49 was expanded in vitro, and the cell
density was adjusted to 1×107/ml, which was implanted
subcutaneously in the groin of C57BL/6 mice (200 μL
per mouse). After the tumors were formed, a group of
experimental mice were euthanized and observed every
three days. All mice were anesthetized with isoflurane
(1.5%) inhalation and sacrificed via cervical dislocation.
Euthanasia can be confirmed with cardiac arrest and
mydriasis in experimental animals. Animals will be
euthanized when the maximum diameter of the tumor will
not be above 20 mm. And the tumor tissues were peeled
off. The average time of mouse tumor model was 19 days.
The duration of the whole experiment was half a year.
After being photographed, the tissue cells were treated.
2.5. Dynamically detect the expression of CD206+ macrophages of tumor-bearing mice in vivo
After the tumor tissues was peeled off, washed once with
PBS, and cut to small pieces 1 mm in diameter, the tissue
fragments were resuspended in 20% bovine serum 1640
culture medium and treated with a gentle MACS tissue
processor (Miltenyi Biotec, Germany). Then the tissue
fragments were removed by a 150 mesh filter, centrifuged
and resuspended (1500 rpm in centrifugal speed, 16.2
cm in centrifugal radius). Thereafter, it was removed
by a 30μm filter (Miltenyi Biotec, Germany) to remove
islet-like cell cluster to obtain single cell suspension.
Multi-color flow cytometry scheme was established with
CD11b-FITC, F4/80-PC7 and CD206-PE single standard
tubes. On this basis, CD11b-FITC+F4/80-PC7+IgG-PE was
taken as negative control tubes and CD11b-FITC+F4/80PC7+CD206-PE as test tubes. The cell suspension was
mixed with the antibodies above, and then it was placed
on ice for 30 min. After that, the reaction was stopped by
being washed with PBS (2mL) once. It was resuspended
in PBS solution (0.5mL) again. CD11b+F4/80+ was taken
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as the characteristics of making gates, and the dynamic
expression of type M2 mononuclear macrophages
characterized by CD206 in cancer tissues of tumor-bearing
mice was analyzed by flow cytometry.
2.6. Statistical methods
Statistical analysis and drawing were performed using
GraphPad Prism 5.0 (version 5.01). Intergroup analysis was
paired Student’s t-test or One-way ANOVA; phenotypic
analysis of CD163- and CD163+ mononuclear macrophages
was ANOVA; Bonferroni was used following the ANOVA;
p < 0.05 showed the difference was statistically significant.
3. Results
3.1. Expression ratio of CD163+ mono-macrophage in
bladder cancer tissue
Mono-macrophages infiltrated in tissue were detected by
flow cytometry (Figure 1A). The expression proportion
of CD45+CD14+CD163+ mono-macrophage subset
in bladder cancer tissue (n = 8) was significantly higher
than that in adjacent normal tissues (n = 3, 67.88 ± 7.2%
vs. 27.05 ± 11.18%, P = 0.001) (Figures 1B and 1C). It is
prompted that CD45+CD14+CD163+ mono-macrophage

subset is significantly increased in bladder cancer
microenvironment, which is one of the characteristics of
tumor immune microenvironment.
3.2. Phenotypic identification of CD163- and CD163+
mono-macrophage subset in bladder cancer tissue
Monocyte macrophages are mainly involved in immune
regulation and neovascularization in the tumor
microenvironment (Arnold et al., 2019). Tie-2, CD31
and VEGFR2 are associated with neovascularization
(Loges et al., 2007; Xu et al., 2019). PD-L1 and CD40 are
important immunoregulatory molecules that are closely
related to the immune response of tumors. Therefore,
we chose the above molecules (Goto et al., 2019). The
expression rate of Tie-2 in CD45+CD14+CD163- monomacrophage subset (43.8 ± 10.12%) was significantly
higher than that in CD45+CD14+CD163+ subset (12.71 ±
3.06 %) (p = 0.000) (Figure 2A). However, the expression
rate of CD40 in CD45+CD14+CD163- mono-macrophage
subset (19.1 ± 2.51%) was significantly lower than that in
CD45+CD14+CD163+ subset (33.91 ± 2.8%) (p = 0.001)
(Figure 2B). There was no significant difference between
the two groups in CD31, PD-L1 and VEGFR2 and other
molecules (p = 0.686, 0.613, 0.452) (Figure 2B). This

Figure 1. Expression ratio of CD163+ mono-macrophage in bladder cancer tissue. Mono-macrophages infiltrating the tissue were
detected by flow cytometry (A). Notably, 80.3% of living cell enrichment regions in total single cell suspension were obtained from
tumor tissue homogenate. Approximately, 17.5% mononuclear macrophages were detected in 80.3% of leukocytes in the preceding
gate. In total, 2.98% mononuclear macrophages were detected in 17.5% of leukocytes in the preceding gate. The expression of the
CD45+CD14+CD163+ mono-macrophage subset in bladder cancer tissues (n = 8) was significantly higher than that in adjacent normal
tissues (B and C) (n = 3, 67.88 ± 7.2% vs. 27.05 ± 11.18%, p = 0.001).
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suggested that CD163+ mono-macrophage subset was
manifested as the phenotype of Tie-2lowCD40high in cancer
tissues.
3.3. Phenotype identification of CD163- and CD163+
mononuclear macrophage subset in adjacent tissues of
bladder cancer
In contrast to the cancerous tissue, the expression rate
of CD40 in CD45+CD14+CD163- mono-macrophage
subset (24.71 ± 2.54%) was significantly lower than that

in CD45+CD14+CD163+ mono-macrophage subset (67.9
± 5.66%) (p = 0.000). There was no significant difference
between the two groups in Tie-2, CD31, PD-L1, VEGFR2
and other molecules (p = 0.885, 0.836, 0.808, 0.713)
(Figure 2C and 2D). This suggested that the CD163+
mono-macrophage subset in normal adjacent tissues was
only manifested as the phenotype of CD40high. For the
comparison of cancer tissues and adjacent tissues, CD40high
is a common feature of CD163+ mono-macrophage subset,

Figure 2. Phenotype identification of CD163- and CD163+ mono-macrophage subsets in 8 bladder cancer tissues (A) and 3 adjacent
tissues of 3 bladder cancer cases (C). Then, the expression levels of Tie-2, CD31, pd-l1, CD40 and VEGFR2 in CD163- and CD163+
mono-macrophage subsets were detected (%) and statistically analyzed (B and D). There was no significant difference between the two
groups in CD31, PD-L1 and VEGFR2 and other molecules (p = 0.686, 0.613, 0.452, respectively) (A and B). There was also no significant
difference between the two groups in Tie-2, CD31, PD-L1, VEGFR2 and other molecules (p = 0.885, 0.836, 0.808, 0.713, respectively)
(C and D).
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suggesting that this molecule may play an important role
in biological functions of the CD163+ mono-macrophage
subset.
3.4. Dynamic expression of CD206+ mononuclear macrophage in bladder cancer tumor-bearing mouse model
Construct tumor-bearing mouse model using MB49.
With the growth of the tumors, three model mice were
euthanized in batches by cutting off necks on the 7th, 10th,
13th, 16th and the 19th day after tumor implantation. The
tumor tissues were peeled off, and the tumor sizes were
recorded (Figure 3A); maximum diameter of tumor was 18
mm, each mouse had only one tumor. After tumor tissues
were treated as single cell suspension, they were counted
by flow cytometry. Mono-macrophages were delineated
by CD11b+F4/80+, and the expression changes of CD206+
subset were detected (Figure 3B). The results showed
that the proportion of CD206+CD11b+F4/80+ infiltrated
by mononuclear macrophage subset gradually increased
with tumor growth (p = 0.015) (Figure 3C), but there was
a downtrend of the proportion of CD206+CD11b+F4/80+

cells on Day 13 that we will find out the reason by
expanding the sample size.
4. Discussion
Tumor microenvironment is the “soil” on which tumor
cells depend, and provides support for the growth and
spread of cancer cells (“seeds”) (Fidler, 2003; Joyce and Pollard, 2009; Quail and Joyce, 2013). The components that
make up the tumor microenvironment are relatively complex, including fibroblasts, stromal stem cells, endothelial
cells, and immune cells. The highly concerned immunological factors are the myeloid derived cells represented by
mono-macrophages (Fukuda et al., 2012; Thevenot et al.,
2014). Mono-macrophages in the tumor microenvironment can promote tumor growth and metastasis in the following several ways (Sica and Mantovani, 2012; Chanmee
et al., 2014). (1) In the aspect of tumor immune escape, as
important antigen-presenting cells, mono-macrophages at
the tumor infiltration site can express a large number of
negative costimulatory molecules, exhibit the characteristics of low expression of human leukocyte antigen DR

Figure 3. Dynamic expression of CD206+ mono-macrophages in a bladder cancer tumor-bearing mouse model. (A) With the growth
of the tumors, three mice were euthanized in batches by cutting off necks on the 7th, 10th, 13th, 16th and 19th days after tumor
implantation. The tumors are shown at different points in time. (B and C) Mono-macrophages were delineated by CD11b+F4/80+,
and the expression changes in the CD206+ subset were detected and statistically analyzed. The results showed that the proportion of
infiltrating CD206+CD11b+F4/80+ mono-macrophages gradually increased with tumor growth (p = 0.015).
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(HLA-DR), which plays an important role in inhibiting
antigen-specific T cells response. (2) In the aspect of angiogenesis, mono-macrophages promote the angiogenesis of
tumor vessels and lymphatics by expressing vascular (lymphatic vessel) growth factors such as vascular endothelial
growth factor (VEGF). In addition, they can directly participate in the differentiation of tumor vessel endothelium
as precursor cells to promote tumor angiogenesis. (3) In
terms of invasion and metastasis, mono-macrophage plays
an important role in invasion and metastasis of tumor by
secreting metalloproteinases, reducing the adhesion between tumor and ground substance and promoting the
degradation of basement membrane. (4) In terms of tumor formation “pre-metastatic niche”, tumor metastasis is
not random, and only a few specific organs may form metastases. Like all solid tumors, bladder cancer requires an
active angiogenesis to support its growth and progression,
Bladder tumor-associated angiogenesis is emerging as an
important prognostic factor and represents a promising
potential therapeutic target for cancer treatment. Monomacrophages in the tumor microenvironment can reach
the pre-metastatic organs prior to the tumor, and create
an immune microenvironment suitable for tumor growth.
This tumor pre-metastatic microenvironment composed
of mono-macrophages and other myeloid derived cells is
called “Pre-metastatic Niche” ( Hiratsuka et al., 2006; GilBernabé et al., 2012; Chanmee et al., 2014). Thus, it can be
seen that mono-macrophages in the tumor microenvironment play a major role in promoting tumor invasion and
metastasis.
Monon-macrophages are highly heterogeneous
groups whose phenotypes may vary in different
microenvironment. This study found that the expression of
CD40 in CD45+CD14+CD163+ mono-macrophage subset
was significantly higher than that in CD45+CD14+CD163mono-macrophage subset in both cancer tissues and
adjacent tissues (Figures 2B and 2D), suggesting that CD40
may play an important role in the biological function for
this subset. Enormous research suggests that the signal
mediated by CD40-CD40L can induce APC activation.
CD40-CD40L signal can also upregulate the expression
of inflammatory cytokines such as Interleukelin-6 (IL-6),
VEGF and tumor necrosis factor-α (TNF-α), participate
in tumor angiogenesis and promote tumor invasion and
metastasis (Chakrabarti et al., 2010; Selvaraj et al., 2014).
Recent studies show that the expression level of CD40
is closely related to its biological effects (Schönbeck and
Libby, 2001). CD40 with a low expression level can promote
cell proliferation and be exempted from the apoptosis;
CD40 with a high expression level can induce apoptosis.
Additionally, it has been reported that CD40 plays a key
role in myeloid-derived suppressor T cell (Treg) expansion
(Pan et al., 2010).
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Angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) can
interact with Tie-2, and Ang-1/Tie-2 signaling promotes
the formation of vascular endothelium and lumen. Ang2 can compete with Ang-1 for binding to Tie-2, thereby
compete to inhibit angiogenesis. Tie-2 mainly promotes
angiogenesis; mono-macrophages characterized as Tie-2+
are also presumed to be involved in the neovascularization
of tumors. In the present study, the expression rate of Tie-2
in the CD45+CD14+CD163- mono-macrophage subset was
significantly higher than that in the CD45+CD14+CD163+
subset (Figures 2A and 2B). These results suggested that
M1-like mono-macrophages may play a more important
role in promoting angiogenesis than do M-2-like monomacrophages.
It was well known that TAMs with an M2-like
phenotype (markers CD163, CD204, and CD206) promote
tumor growth while M1-like TAMs (CD68, CD80, and
CD86) may inhibit tumor growth (Wu et al., 2020). In this
study, we found that the number of CD206+ mononuclear
macrophage subset gets bigger along with the tumor
growth (Figures 3B and 3C). Here, we speculate that
CD206 may become a therapeutic target in bladder cancer,
and clinically we can also actively detect the expression
of CD206 to calculate tumor load, determine treatment
responses, and observe patient prognosis (Wang et al.,
2020).
In summary, we compared and analyzed the expression
characteristics of mono-macrophages in the bladder cancer
microenvironment. Functional experiments require the
adequate tumor infiltration of mono-macrophages in
bladder cancer, which restricts functional research on
bladder cancer. We will strive to improve this part of our
follow-up work. Our results showed that CD40 is highly
expressed in M2-like mono-macrophages and that Tie-2
is highly expressed in M1-like mono-macrophages. The
phenotype of M2-like mono-macrophages was identified
as CD45+CD14+CD163+CD40highTie-2low for the first time,
which established a foundation for further studies on
the biological function of this subgroup. As well, CD206
might be an important therapeutic target that needs to be
validated in more bladder cancer samples.
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